Green Valley Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Green Valley Investors's GILD Position: Q3 2018 in Review
Green Valley Investors sold out of Gilead Sciences (GILD) in Q3 2018, closing a stake of 289,546 shares — an estimated $20.5M sold.
Green Valley Investors first reported a position in GILD in Q4 2013 and held it in 19 quarters. The position peaked at $351M in Q2 2015. 1,528 funds tracked by Wall St. Rank hold GILD as of Q3 2018.
- Green Valley Investors reported no remaining Gilead Sciences position as of Q3 2018 after selling out during the quarter.
- Green Valley Investors sold 289,546 Gilead Sciences shares in Q3 2018, an estimated $20.5M.
- Green Valley Investors first reported a position in Gilead Sciences in Q4 2013 and held it in 19 quarters.
- Green Valley Investors's Gilead Sciences position peaked at $351M in Q2 2015.
- 1,528 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2018.
Based on Green Valley Investors's 13F filing for Q3 2018, filed 13 Nov 2018.